| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.17B | -9.7% |
| Cost of Revenue | $889.1M | -13.1% |
| Gross Profit | $277.5M | +3.2% |
| R&D Expense | $1.3M | +18.2% |
| SG&A Expense | $169.8M | -8.8% |
| Operating Income | $21.4M | +230.3% |
| Pre-tax Income | -$130.7M | +20.7% |
| Income Tax | $11.7M | -14.2% |
| Net Income | -$142.4M | +20.2% |
| EPS (Basic) | -$1.22 | +66.7% |
| EPS (Diluted) | -$1.22 | +66.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.8M | -69.5% |
| Accounts Receivable | $184.1M | -11.0% |
| Inventory | $15.2M | +6.3% |
| Current Assets | $279.9M | -13.4% |
| Total Assets | $1.04B | -10.4% |
| Current Liabilities | $591.8M | +30.1% |
| Long-term Debt | $1.25B | -18.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.5M | -274.5% |
| Capital Expenditures | $14.6M | +25.0% |
| Investing Cash Flow | -$9.3M | -143.2% |
| Financing Cash Flow | $98.7M | +55.7% |
| Free Cash Flow | -$126.1M | -204.3% |
| Total Liabilities |
| $1.70B |
| -18.3% |
| Stockholders' Equity | -$666.8M | +28.0% |